ST
TEVA icon

Spot Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Spot Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3.19M Sell
181,100
-5,300
-3% -$119K 0.05% 482
2017
Q2 		$6.19M Buy
186,400
+83,900
+82% +$2.6M 0.12% 177
2017
Q1 		$3.29M Sell
102,500
-64,100
-38% -$2.19M 0.11% 177
2016
Q4 		$6.04M Buy
166,600
+49,700
+43% +$1.98M 0.14% 164
2016
Q3 		$5.38M Sell
116,900
-102,300
-47% -$5.34M 0.11% 234
2016
Q2 		$11M Buy
219,200
+97,400
+80% +$5.19M 0.19% 91
2016
Q1 		$6.52M Sell
121,800
-25,000
-17% -$1.47M 0.12% 218
2015
Q4 		$9.64M Buy
146,800
+89,400
+156% +$5.52M 0.1% 246
2015
Q3 		$3.24M Sell
57,400
-30,100
-34% -$1.95M 0.03% 766
2015
Q2 		$5.17M Buy
87,500
+8,600
+11% +$531K 0.05% 546
2015
Q1 		$4.92M Sell
78,900
-132,800
-63% -$7.72M 0.05% 565
2014
Q4 		$12.2M Sell
211,700
-76,700
-27% -$4.27M 0.08% 330
2014
Q3 		$15.5M Buy
288,400
+9,000
+3% +$477K 0.08% 328
2014
Q2 		$14.6M Buy
279,400
+89,000
+47% +$4.55M 0.07% 361
2014
Q1 		$10.1M Buy
190,400
+164,900
+647% +$7.62M 0.06% 452
2013
Q4 		$1.02M Sell
25,500
-102,000
-80% -$4.02M 0.01% 1965
2013
Q3 		$4.82M Buy
127,500
+86,700
+213% +$3.38M 0.03% 739
2013
Q2 		$1.6M Buy
+40,800
New +$1.59M 0.01% 1552

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Spot Trading's TEVA Position: Q2 2017 in Review

Spot Trading sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 46,178 shares — an estimated $1.43M sold.

Spot Trading first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $31.2M in Q1 2014. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Spot Trading reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Spot Trading sold 46,178 Teva Pharmaceuticals shares in Q2 2017, an estimated $1.43M.
  • Spot Trading first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Spot Trading's Teva Pharmaceuticals position peaked at $31.2M in Q1 2014.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Spot Trading's 13F filing for Q2 2017, filed 27 Jul 2017.